Examining visual outcomes of bilateral trifocal IOL

Article

A new trifocal diffractive IOL (FineVision trifocal IOL, PhysIOL), implanted bilaterally, achieved a full range of adequate vision, satisfactory contrast sensitivity, and a lack of significant adverse photic phenomena, according to Spanish researchers reporting in BMC Ophthalmology.

A new trifocal diffractive IOL (FineVision trifocal IOL, PhysIOL), implanted bilaterally, achieved a full range of adequate vision, satisfactory contrast sensitivity, and a lack of significant adverse photic phenomena, according to Spanish researchers reporting in BMC Ophthalmology.

In a prospective, nonrandomized, observational study, 44 eyes of 22 patients were assessed before and three months after cataract surgery and IOL implantation. A Topcon KR-1 W wavefront analyser was used to determine aberrations, and LogMAR visual acuity was measured at distance, intermediate, and near. Contrast sensitivity was estimated using the Pelli-Robson letter chart and the CSV-1000 test. Both photopic and mesopic defocus curve testing was performed, and the Halo v1.0 program was used to assess adverse photic phenomena.

The findings:

• Mesopic pupil diameter mean aberration values were: total HOA RMS 0.41 ± 0.30 μm; coma 0.32 ± 0.22 μm; spherical aberration 0.21 ± 0.20 μm. 

• Binocular logMAR measurements were −0.05 ± 0.05 for corrected distance visual acuity, 0.15 ± 0.10 for distance corrected intermediate visual acuity, and 0.06 ± 0.10 for distance corrected near visual acuity.

• Mean Pelli-Robson contrast sensitivity was 1.40 ± 0.14 log units.

 

• CSV-1000 contrast sensitivity was 1.64 ± 0.14 log units at 3 cycles per degree (cpd), 1.77 ± 0.18 log units at 6 cpd, 1.44 ± 0.24 log units at cpd, and 0.98 ± 0.24 log units at 18 cpd.

• Significant differences were observed in the photopic and mesopic defocus curves.

• The mean disturbance index was 0.28 ± 0.22.

“Distance visual outcomes of the trifocal IOL FineVision were similar to those of monofocal IOLs, while near visual outcomes resembled those of bifocal diffractive IOLs,” the researchers wrote. “In addition, a real improvement in intermediate vision was noted, which was not associated with impairment of far or near vision. Trifocality did not lead to increased subjective visual discomfort in comparison to bifocality. Moreover, the indications and limitations of the FineVision lens do not differ from those of other diffractive lenses.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.